Used in research settings as a selective inhibitor of 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1), an enzyme involved in cortisol metabolism. It is studied for its potential to modulate glucocorticoid activity, which may have implications in metabolic disorders such as type 2 diabetes, obesity, and insulin resistance. By inhibiting 11β-HSD1, it helps reduce local cortisol levels in tissues like liver and adipose, improving insulin sensitivity and glucose regulation in preclinical models. It serves as a tool compound for understanding glucocorticoid-related pathophysiology and evaluating therapeutic strategies targeting hormone regulation in metabolic disease.